LUCD - Lucid nearing Medicare coverage for EsoGuard test, maintain at Buy: BTIG
2025-07-28 14:36:40 ET
More on Lucid Diagnostics
- Lucid Diagnostics Inc. (LUCD) Q1 2025 Business Update Call Transcript
- Lucid says meeting scheduled to determine Medicare coverage for cancer test
- Lucid Diagnostics signals expanded market reach and $41M pro forma cash following commercial and clinical advances
- Seeking Alpha’s Quant Rating on Lucid Diagnostics
- Historical earnings data for Lucid Diagnostics